Cargando…

Differential Impact of a Multicomponent Goals-of-Care Program in Patients with Hematologic and Solid Malignancies

SIMPLE SUMMARY: Goals-of-care discussions can help patients to understand their illness and to share their values and treatment preferences with their clinicians. Here, we compared the impact of an institution-wide goals-of-care program on intensive care unit (ICU) mortality between patients with he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, David, Ahmed, Sairah, Nortje, Nico, George, Marina, Andersen, Clark R., Wilson, Kaycee, Urbauer, Diana, Flowers, Christopher, Bruera, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001115/ https://www.ncbi.nlm.nih.gov/pubmed/36900298 http://dx.doi.org/10.3390/cancers15051507

Ejemplares similares

Just-in-Time Decision Making: Preliminary Findings of a Goals of Care Rapid Response Team
por: Zhukovsky, Donna S., et al.
Publicado: (2023)

Goals of Care Rapid Response Team at a Comprehensive Cancer Center: Feasibility and Preliminary Outcomes (S537)
por: Zhukovsky, Donna, et al.
Publicado: (2022)

Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic
por: Yennu, Sriram, et al.
Publicado: (2012)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

The Importance of Facilitating Goal-Concordant Care (GCC) in a Pandemic: The MD Anderson Experience with hospitalized COVID-19 positive patients
por: Muthu, Mayoora, et al.
Publicado: (2023)

Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial
por: Yennurajalingam, Sriram, et al.
Publicado: (2022)

Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012)

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
por: Federico, Mario, et al.
Publicado: (2011)

Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique
por: Wang, Yujie, et al.
Publicado: (2016)

Nutritional status of children and adolescents at diagnosis of hematological and solid malignancies
por: Lemos, Priscila dos Santos Maia, et al.
Publicado: (2014)

Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
por: Mancini, Stéphane J.C., et al.
Publicado: (2021)

Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2022)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
por: Zhang, Linda, et al.
Publicado: (2022)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
por: Ellis, Leigh, et al.
Publicado: (2010)

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
por: Lin, Swan, et al.
Publicado: (2019)

Acute Respiratory Failure in Patients with Hematologic and Solid Malignancies: Global Approach
por: Sethi, Sakshi, et al.
Publicado: (2017)

Thirty-Two Case Reports of Synchronous Hematological Malignancy and Solid Tumor
por: Liu, Sha, et al.
Publicado: (2019)

Risk of infection associated with targeted therapies for solid organ and hematological malignancies
por: Ruiz-Camps, Isabel, et al.
Publicado: (2021)

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
por: Zhou, Qinfeng, et al.
Publicado: (2022)

Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
por: McBride, Ali, et al.
Publicado: (2012)

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021)

The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
por: Shaw, Jaime L., et al.
Publicado: (2021)

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections
por: Prakash, Rishab, et al.
Publicado: (2022)

The Hidden Curriculum and Integrating Cure- and Care-Based Approaches to Medicine
por: Choudhury, Divya, et al.
Publicado: (2020)

272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019)

Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies
por: Roskams-Hieter, Breeshey, et al.
Publicado: (2022)

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2018)

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies
por: Ma, Jennifer, et al.
Publicado: (2018)

Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies
por: Figueroa, Rocío, et al.
Publicado: (2019)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies
por: Ma, Xuefei, et al.
Publicado: (2022)

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors
por: Ravi, Dashnamoorthy, et al.
Publicado: (2022)

Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding
por: Alwhaibi, Abdulrahman M., et al.
Publicado: (2023)

Cap-Independent Translation in Hematological Malignancies
por: Horvilleur, Emilie, et al.
Publicado: (2015)

Ethical misconduct by registered physiotherapists in South Africa (2007–2013): A mixed methods approach
por: Hoffmann, Willem A., et al.
Publicado: (2015)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4i7lkjqg4gs08125imdms81fqu